IL-4 inhibits the TNF-α induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-α to induce apoptotic and cytokine responses by RCC …

C Falkensammer, K Jöhrer, H Gander… - Cancer Immunology …, 2006 - Springer
C Falkensammer, K Jöhrer, H Gander, R Ramoner, T Putz, A Rahm, R Greil, G Bartsch…
Cancer Immunology, Immunotherapy, 2006Springer
Objective: While previous reports clearly demonstrated antiproliferative effects of IL-4 on
renal cell carcinoma (RCC) in vitro, the administration of IL-4 to patients with metastatic RCC
in clinical trials could not recapitulate the promising preclinical results. In the present study
we wanted to examine the context of IL-4 action and to establish conditions of enhanced IL-4
efficacy. Methods: Primary and permanent human RCC cells were cultured in either serum-
supplemented or chemically defined, serum-free culture medium in the presence or absence …
Abstract
Objective: While previous reports clearly demonstrated antiproliferative effects of IL-4 on renal cell carcinoma (RCC) in vitro, the administration of IL-4 to patients with metastatic RCC in clinical trials could not recapitulate the promising preclinical results. In the present study we wanted to examine the context of IL-4 action and to establish conditions of enhanced IL-4 efficacy. Methods: Primary and permanent human RCC cells were cultured in either serum-supplemented or chemically defined, serum-free culture medium in the presence or absence of cytokines. Cell proliferation was assessed as [3H]-thymidine incorporation. Cell apoptosis was measured using the fluorescent DNA intercalator 7-aminoactinomycin D and flow cytometry. In addition, culture media conditioned by RCC were subjected to cytokine antibody array and cytokine multiplex analysis. Results: Our results indicate that the previously reported antiproliferative effects of IL-4 are serum-dependent. Under serum-free conditions, IL-4 failed to exhibit growth-inhibitory effects or was even growth-stimulatory. In a chemically defined, serum-free medium (AIM-V), however, IL-4 inhibited the TNF-α induced proliferation of RCC. IL-4 and TNF-α synergistically induced apoptosis of RCC as well as a complex cytokine response by RCC, which included the synergistic upregulation of RANTES and MCP-1. Conclusions: IL-4 alone has little effect on the spontaneous proliferation of RCC but can prevent the enhancement of proliferation induced by growth promoters like FBS and TNF-α. The concomitant growth inhibitory, apoptosis-inducing, and cytokine-enhancing effects of IL-4 in combination with TNF-α on RCC support the view that Th2 cytokines may be required for productive immune responses against RCC.
Springer